PENTAX Medical Launches Innovative J10 Series Endoscopic Ultrasound Gastroscopes In the USA

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

September 15, 2020

PENTAX Medical has announced the launch of the new J10 Series Ultrasound Video Gastroscopes.

In assessing GI diseases, endoscopic ultrasound (EUS) is a minimally invasive and highly accurate procedure that uses high-frequency sound waves to produce detailed images of tissue and surrounding organs such as the pancreas and liver. While used primarily for diagnostic procedures such as EUS-guided Fine Needle Aspiration (EUS-FNA), EUS-guided Fine Needle Biopsy (EUS-FNB), and tumor staging, there has been a shift towards using EUS for interventional procedures and to treat pancreaticobiliary diseases as a less-invasive option than ERCP.

The new PENTAX Medical J10 Series Ultrasound Video Gastroscopes deliver on both clinical and market needs, offering ergonomic design, renowned image quality and enhanced maneuverability as an EUS solution.

With ultrasound gastroscopes, high functionality and performance are critical for success, given that indications are so varied. Designed for optimal procedural efficiency in EUS, the new J10 Series Ultrasound Video Gastroscopes provide a lightweight and ergonomic control body design to ensure stability and ease of intubation while reducing hand fatigue. With a proven PENTAX-Hitachi image quality to support visual certainty and diagnoses, the J10 Series produces greater detail, clearer delineation, and superior penetration. Additionally, maneuvering, device control, and instrument compatibility are augmented with shorter rigid distal section lengths, increased tip deflection, smaller bending radius and an enlarged working channel.

“With the immense success of the J10 Series endoscopes since their introduction in other global regions, we are now very pleased and excited for their introduction in the USA as well,” stated Gerald W. Bottero, Global President of PENTAX Medical. “With a focus on exceptional maneuverability and high-definition endoscopic imaging, the J10 Series provides an innovative solution for performing endoscopic evaluations, increasing diagnostic capabilities, and determining pathways for effective patient management.”

Specific enhancements with the new J10 Series Ultrasound Video Gastroscopes include increased linear scope scan angle of 150° for broader imaging, increased frequency (13MHz) for near-field exploration, widened depth of field range (3mm–100mm), increased angulations to optimize access in the GI tract, and sealed elevator wire channels to help reduce risk of cross-contamination. The EG38-J10UT also has an enlarged instrument channel width (4mm), expanding therapeutic capabilities to advance EUS-guided intervention while providing full control of the procedure.

The new J10 Series is really a step forward in the set-up and portfolio of endoscopic ultrasound,” said Dr. Paolo G. Arcidiacono, Ospedale San Raffaele, Milan, Italy. “It is a significant improvement on both the endoscopic and the endosonographic side. Particularly for therapeutic procedures, the improved endoscopic view has solved previous compromises.”

The J10 Series is commercially available now. An exclusive Virtual Launch Event is scheduled for October 14, 2020 at 6:00 PM EDT. Three renowned endoscopic ultrasound experts will present difficult EUS cases and discuss the potential benefits and differences of the new J10 Series lineup.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.